CXCR2 and neoplasm: In fact, a more glycolytic neutrophil (ckit-CXCR2+ phenotype) is unable to induce T cell death and inhibit interferon-γ (IFN-γ) production by T-cells, thereby enhancing anti-tumor immunity (47).